Search
for

    Sort by

    Research 151–180 of 338

    1. 1406 DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION The Journal of Urology · 2010
    2. Slow progress in prostate cancer BJUI · 2007
    3. Antiandrogens CRC Press eBooks · 2022
    4. Modulation der Hitzesensitivität im Prostatakarzinom in vitro: Der Einfluss der Androgenachse 2022
    5. The challenging role of antiandrogens in the management of polycystic ovary syndrome Elsevier eBooks · 2021
    6. Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2 Research Square (Research Square) · 2021 · 1 citations
    7. Dynamet wins titanium award Metal Powder Report · 2013
    8. Hormone Blocking Anticancer Drugs 2015
    9. A guide to diagnosis and management of hypertrichosis JAAD reviews. · 2025 · 1 citations
    10. Thiohydrazides in the Synthesis of Functionalized Extranuclear Heterosteroids 2023
    11. Research progress on drug-induced gynecomastia 药物不良反应杂志 · 2015
    12. 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY The Journal of Urology · 2010
    13. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013 · 48 citations
    14. (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production Bioorganic & Medicinal Chemistry Letters · 2007 · 14 citations
    15. Pantolactams as androgen receptor antagonists for the topical suppression of sebum production Bioorganic & Medicinal Chemistry Letters · 2011 · 5 citations
    16. Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships Current Medicinal Chemistry · 2000 · 204 citations
    17. HairMax LaserComb® Laser Phototherapy Device in the Treatment of Male Androgenetic Alopecia Clinical Drug Investigation · 2009 · 160 citations
    18. Sex differences in COVID-19: the role of androgens in disease severity and progression Endocrine · 2020 · 121 citations
    19. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer Communications biology · 2020 · 113 citations
    20. Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia International Journal of Nanomedicine · 2014 · 89 citations
    21. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies European Journal of Clinical Pharmacology · 2020 · 77 citations
    22. Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation PLoS ONE · 2013 · 63 citations
    23. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer Breast Cancer Research and Treatment · 2016 · 59 citations
    24. Promotion of Hair Growth by<i>Rosmarinus officinalis</i>Leaf Extract Phytotherapy Research · 2012 · 49 citations
    25. The Androgen Receptor Antagonizes Wnt/β-Catenin Signaling in Epidermal Stem Cells Journal of Investigative Dermatology · 2015 · 46 citations
    26. Are sex discordant outcomes in COVID-19 related to sex hormones? Seminars in Oncology · 2020 · 42 citations
    27. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    28. Androgens in women Journal of The American Academy of Dermatology · 2018 · 34 citations
    29. Gender-Affirming Hormone Therapy for Transgender Females Clinical Obstetrics and Gynecology · 2018 · 32 citations
    30. Understanding and Addressing Hair Disorders in Transgender Individuals American Journal of Clinical Dermatology · 2018 · 32 citations